EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

Clinical Evaluation of a Stool‐Based Molecular Point‐of‐Care Test Kit for Noninvasive Detection of Helicobacter pylori Infection and Clarithromycin Resistance

Momoko Tsuda iD, Yoshiyuki Watanabe iD, Kimitoshi Kubo iD, Mototsugu Kato iD

Canadian Journal of Gastroenterology and Hepatology · 2026

DOI: 10.1155/cjgh/4505059 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Canadian Journal of Gastroenterology and Hepatology, 2026. Verfasst von Momoko Tsuda und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, National Hospital Organization Hakodate Medical Center, Hakodate, Japan. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori, Clarithromycin, Feces. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mizuho Medy Co., Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Although molecular point‐of‐care testing using intragastric fluid has improved the speed and accuracy of Helicobacter pylori (H. pylori) diagnosis and clarithromycin (CAM) resistance detection, it still requires endoscopy, which limits its application in routine screening and settings where invasive procedures cannot be performed. We aimed to evaluate the clinical performance of the Smart Gene™ molecular point‐of‐care testing kit using stool specimens for H. pylori infection and CAM resistance detection.

Methods

We used stool specimens from 75 patients with suspected H. pylori infection. All participants underwent conventional diagnostic tests (urea breath test, stool antigen test, culture, and real‐time polymerase chain reaction). CAM resistance–associated mutations (Positions 2142 and 2143 in the 23S rRNA gene) were analyzed using pyrosequencing.

Results

The stool‐based Smart Gene kit demonstrated a sensitivity of 96.1% and specificity of 100% for H. pylori detection. The sensitivity and specificity for detecting CAM resistance were 100% and 97.0%, respectively, compared to antibiotic susceptibility testing. High concordance was observed between the intragastric polymerase chain reaction and culture results despite the lower stool DNA concentration. The results were obtained within approximately 1 h.

Conclusions

The Smart Gene™ stool kit offers a rapid, accurate, and noninvasive alternative for diagnosing H. pylori infection and CAM resistance. Its diagnostic performance is comparable to that of the gold‐standard invasive methods while offering practical advantages for outpatient use, mass screening, and nonendoscopy‐feasible populations. This approach increases early H. pylori detection and improves eradication outcomes and contributes to more effective gastric cancer prevention strategies (approval number: R4‐0426001).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsHelicobacter pyloriClarithromycinFecesDrug Resistance, BacterialAnti-Bacterial AgentsPoint-of-Care TestingHumansFemaleMaleSensitivity and SpecificityMiddle AgedAgedAdultRNA, Ribosomal, 23SRapid Diagnostic TestsMicrobial Sensitivity TestsPoint-of-Care Systems

Stichwörter der Autor:innen

H. pyloriintragastric fluidmicrobial sensitivity testspoint-of-care testingpolymerase chain reactionstool

Substanzen

ClarithromycinAnti-Bacterial AgentsRNA, Ribosomal, 23S

Autor:innen und Institutionen

  • Department of Gastroenterology, National Hospital Organization Hakodate Medical Center, Hakodate, Japan.
  • Department of Gastroenterology, Public Interest Foundation Hokkaido Cancer Society, Sapporo, Japan.
  • Department of Internal Medicine, Kawasaki Rinko General Hospital, Kawasaki, Japan.
  • Department of Internal Medicine, Division of Gastroenterology, St. Marianna University School of Medicine, Kawasaki, Japan, marianna-u.ac.jp.

ORCID-Profile: Momoko Tsuda, Yoshiyuki Watanabe, Kimitoshi Kubo, Mototsugu Kato

Förderung

  • Mizuho Medy Co., Ltd.

Zitieren

APA

Tsuda, M., Watanabe, Y., Kubo, K., & Kato, M. (2026). Clinical Evaluation of a Stool‐Based Molecular Point‐of‐Care Test Kit for Noninvasive Detection of Helicobacter pylori Infection and Clarithromycin Resistance. Canadian Journal of Gastroenterology and Hepatology. https://doi.org/10.1155/cjgh/4505059

Vancouver

Tsuda M, Watanabe Y, Kubo K, Kato M. Clinical Evaluation of a Stool‐Based Molecular Point‐of‐Care Test Kit for Noninvasive Detection of Helicobacter pylori Infection and Clarithromycin Resistance. Canadian Journal of Gastroenterology and Hepatology. 2026. doi:10.1155/cjgh/4505059

BibTeX
@article{Tsuda2026,
  author = {Tsuda, Momoko and Watanabe, Yoshiyuki and Kubo, Kimitoshi and Kato, Mototsugu},
  title = {Clinical Evaluation of a Stool‐Based Molecular Point‐of‐Care Test Kit for Noninvasive Detection of Helicobacter pylori Infection and Clarithromycin Resistance},
  journal = {Canadian Journal of Gastroenterology and Hepatology},
  year = {2026},
  doi = {10.1155/cjgh/4505059}
}
Kostenlos starten →